Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Verseau Therapeutics

Request full access

Verseau is the Macrophage Company Transforming Immunotherapy

Newton, United StatesFounded 2017Biotech & Life Sciences

About Verseau Therapeutics

Verseau Therapeutics is a biotech startup that operates in the field of cancer immunotherapies. The company's primary focus is on developing a new class of treatments that stimulate the conversion of certain types of cells, specifically M2 macrophages, into a different type, M1 macrophages. This process, known as macrophage repolarization, triggers a coordinated immune response to combat cancer. In simpler terms, Verseau is working on a way to make the body's own immune system more effective in fighting cancer.

The company's proprietary discovery engine, a unique tool that helps them identify and validate potential targets for treatment, has already identified over 20 targets for regulating cell biology. Their two main programs, which focus on PSGL-1 and VSIG4, are making significant progress towards clinical trials.

Verseau's clients are primarily in the healthcare sector, including hospitals, clinics, and other medical institutions, as well as individual patients suffering from cancer. The company operates in the biotech market, which is highly competitive and research-intensive.

Verseau's business model is based on research and development of innovative cancer treatments. The company invests heavily in research to discover and develop new therapies, which are then patented and sold to healthcare providers. The company makes money by selling these patented therapies and treatments.

Source: Dealroom company data

At a glance

Status
Operational
Employees
6
Open positions
None listed
Dealroom signal
59.0/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Spinout, Biotech and Pharma, radar de l'innovation, observatoire greentech, DT and LS, science-based
Client focus
B2C

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VCOther financing Oct 2019 $50M $200M 20/20 HealthCare Partners · Highlight Capital · Alexandria Venture Investments · 3SBio —
SERIES BOther financing Feb 2019 $15M $60M 3SBio —
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Verseau Therapeutics website traffic

Latest recorded traffic for Verseau Therapeutics is 820 monthly website visits, up 256.5% over the last three months. Verseau Therapeutics's team grew 0% over the past year.

Latest monthly visits820 3-month web change+256.5% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Verseau Therapeutics in the Newton ecosystem

Live from Dealroom

The Verseau Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

  • 3SBio
  • 20/20 HealthCare Partners
  • Highlight Capital
  • Alexandria Venture Investments
  • Yonghua Capital

Other known investors1 additional known investor

  • Massachusetts Institute of Technology
Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Verseau Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Verseau Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.